Challenges Of Drug Development In L-dopa-Naive Subjects With Diagnosis Of Early Parkinson's Disease
Source: Worldwide Clinical Trials
Tomislav Babic, MD, Ph.D., Vice President of Neuroscience at Worldwide Clinical Trials discusses the potential benefit of a delay in initiation for symptomatic treatment with levodopa in early Parkinson's disease patients.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Worldwide Clinical Trials
This website uses cookies to ensure you get the best experience on our website. Learn more